Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid (2015)
- Authors:
- USP affiliated authors: MUSSI, MARISA MARCIA - FMRP ; ISAAC, MYRIAM DE LIMA - FMRP ; CERVI, MARIA CÉLIA - FMRP
- Unidade: FMRP
- DOI: 10.1001/jamapediatrics.2014.3158
- Subjects: TUBERCULOSE (TRATAMENTO); QUIMIOTERAPIA COMBINADA
- Language: Inglês
- Imprenta:
- Source:
- Título: JAMA Pediatrics
- ISSN: 2168-6203
- Volume/Número/Paginação/Ano: v. 169, n. 3, p. 247-255, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VILLARINO, M. Elsa et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatrics, v. 169, n. 3, p. 247-255, 2015Tradução . . Disponível em: https://doi.org/10.1001/jamapediatrics.2014.3158. Acesso em: 13 fev. 2026. -
APA
Villarino, M. E., Scott, N. A., Weis, S. E., Weiner, M., Conde, M. B., Jones, B., et al. (2015). Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatrics, 169( 3), 247-255. doi:10.1001/jamapediatrics.2014.3158 -
NLM
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, Mussi-Pinhata MM, Isaac M de L, Cervi MC. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid [Internet]. JAMA Pediatrics. 2015 ; 169( 3): 247-255.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1001/jamapediatrics.2014.3158 -
Vancouver
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, Mussi-Pinhata MM, Isaac M de L, Cervi MC. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid [Internet]. JAMA Pediatrics. 2015 ; 169( 3): 247-255.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1001/jamapediatrics.2014.3158 - HIV-1 drug resistance and second-line treatment in children randomized to switch at low versus higher RNA thresholds
- Cryptococcus meningoencephalitis in four children: case report
- Bone paracoccidioidomycosis: case report
- Reactivation congenital toxoplasmosis in mother infected by human immunodeficiency(HIV-1): case report
- Bone mass evaluation in children infected by HIV-1 using highly active retroviral treatment (HAART)
- Neonatal citrobacter koseri brain access: case report
- Rescue therapy with enfuvirtide in adolescents infected with the human immunodeficiency virus (HIV-1): case reports
- Gigant cell glioblastoma in adolescents with infection by the human immunodeficiency virus (HIV-1) and progressive multifocal leukoencephalopathy
- Dyslipidemia in a cohort of HIV-infected latin american children receiving highly active antiretroviral therapy
- Valor de achados clínicos, testes imunológicos, PCR, IgA e P24 para diagnóstico de Infecção pelo HIV
Informações sobre o DOI: 10.1001/jamapediatrics.2014.3158 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
